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Infection riskInﬂuenza virus may be transmitted through the respiratory route by inhalation of an aerosol of non-
sedimenting droplets, or by deposition of sedimenting droplets in the upper respiratory tract. Whichever of
these is the predominant route for infection with inﬂuenza virus has been subject of continuing debate,
resulting in detailed studies of aerosol versus droplet exposure. A decisive knowledge gap preventing a
satisfying conclusion is absence of a well deﬁned human dose response model for inﬂuenza virus.
This study uses a hierarchical approach generalizing over twelve human challenge studies collected in a
literature search. Distinction is made between aerosol and intranasal inoculation. The results indicate high
infectivity via either route, but intranasal inoculation leads to about 20 times lower infectivity than when the
virus is delivered in an inhalable aerosol.
A scenario study characterizing exposure to airborne virus near a coughing infected person in a room with
little ventilation demonstrates that with these dose response models the probabilities of infection by either
aerosol or sedimenting droplets are approximately equal. Droplet transmission results in a slightly higher
illness risk due to the higher doses involved.
Establishing a dose response model for inﬂuenza provides a ﬁrm basis for studies of interventions reducing
exposure to different classes of infectious particles. More studies are needed to clarify the role of different
modes of transmission in other settings.se Control, Epidemiology and
he Netherlands. Fax: +31 30
.
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Transmission of inﬂuenza is thought to occur through contact with
small infectious particles. Infectious virus present in or on the
mucosae of the upper respiratory tract is expelled through coughing
or sneezing, or even through normal exhalation, producing small
droplets that may contain various amounts of virus (Fabian et al.,
2008; Blachere et al., 2009). Droplets that are small enough may
evaporate rapidly, leaving a microscopic particle that can remain
suspended in air for an indeﬁnite time (Riley, 1974). While part of the
produced infectious particles may be small enough for a non-
sedimenting aerosol, the remainder of the expelled droplets is bigger
and tends to be removed from the air by sedimentation (Duguid,
1946). Virus present on surfaces (skin or inanimate) may be
transferred to mucosa by hand and still cause infection (Ryan et al.,
2001). Virus may thus infect by different routes. The relativeimportance of these routes for transmission has been debated
intensively but it still remains unclear if any route is dominant
(Tellier, 2006; Weber and Stilianakis, 2008).
The different modes of transmission of respiratory infections may
be studied by quantitative modelling of production of droplets
containing virus and their transport to mucosal surfaces in a
susceptible host (Xie et al., 2007; Atkinson and Wein, 2008; Nicas
and Jones, 2009). Although such studies describe exposure to
respiratory virus with considerable sophistication, one essential
stage in the infection chain, the dose response relation for infection,
has remained relatively obscure. Infectivity estimates are based on
small data sets containing few observations and biological variation
(heterogeneity) in infectivity is ignored.
The present paper attempts to ﬁll this gap by using a hierarchical
approach to dose response modelling, based on data from several
human challenge studies reported in scientiﬁc journals. This allows us
to provide a quantitative description of the infectivity of inﬂuenza A
virus in humans, either by aerosol inoculation or by intranasal droplet
inoculation, including its heterogeneity among hosts and virus
isolates. Based on these dose response models, improved estimates
of the risk of infection (and of acute respiratory symptoms) can be
Table 1
Wild-type inﬂuenza virus challenge studies with aerosol inoculation.
Reference Virus type Dose (TCID50) Exposed Infected Ill
Henle et al. (1946) A (F-12) 0.6×1010a 4 −b 4
0.6×1010a 4 −b 4
0.6×109a 4 −b 1
0.6×108a 4 −b 1
A (F-99) 0.6×108.5a 6 −b 5
0.6×108.5a 4 −b 4
0.6×107.5a 6 −b 2
A (PR-8) 0.6×108.2a 33 −b 27
Jao et al. (1965) A2 (Elisberg) 30 30 −c 12
Alford et al. (1966) A2/Bethesda/10/63 126 3 0 0d
78 3 0 0d
59 3 1 0
1 1 1 1
2 4 1 0
5 9 4 3
a Not tissue culture but ID50 in chick embryos.
b Not studied.
c Virus excretion and seroconversion studied but not reported.
d These subjects were presumably immune, as they had high antibody levels to the
virus.
Table 2
Wild-type inﬂuenza virus challenge studies with nasal inoculation.
Reference Virus type Dose
(TCID50)
Exposed Infected Ill
Henle et al.
(1946)
A (F-12) 1010a 4 −b 1
A (F-99) 108.5a 6 −b 0
Murphy et al.
(1973)
A/Bethesda/88 (H3N2) 104.5 7 7 7c
Murphy et al.
(1980)
A/Hong Kong/77 (H1N1) 104.2 6 6 5
A/Udorn/72 (H3N2) 104.0 6 5 5
A/Alaska/77 (H3N2) 104.2 8 8 4
Clements et al.
(1983)
A/Alaska/6/77 (H3N2) 104.2 8 8 4
Clements et al.
(1984b)
A/Washington/897/80
(H3N2)
106.0 24 23 11
Clements et al.
(1984a)
A/Washington/897/80
(H3N2)d
106.0 24 23 11
Murphy et al.
(1984)
A/California/10/78 (H1N1) 104.0 9 9 5
Murphy et al.
(1985)
A/Washington/897/80
(H3N2)d
106.0 24 23 11
Clements et al.
(1986)
A/Washington/897/80
(H3N2)d
106.0 24 23 11
Snyder et al.
(1986)
A/California/10/78 (H1N1) 104.5 14 13 6
A/Korea/1/82 (H3N2) 106.2 14 14 7
Sears et al.
(1988)
A/Texas/1/85 (H1N1) 106.4 28 26 12
A/Bethesda/1/85 (H3N2) 107.0 10 10 3
Youngner et al.
(1994)
A/Kawasaki/9/86 (H1N1) 107.0 14 14 6
a Not tissue culture but ID50 in chick embryos.
b Not studied.
c Of these subjects, 6 had severe symptoms with fever, 1 hadmild symptoms without
fever.
d Same as Clements et al. (1984b).
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Fig. 1. Counts of particles of various diameters in air expelled by (90) coughs (Loudon
and Roberts, 1967).
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exposure scenario the relative strengths of either transmission mode
can then be estimated.
The improved dose response information contributes to quantita-
tive estimates of the infectious droplet transmission process by
including variation in host susceptibility as well as variation in
infectivity among different virus isolates.
Dose response assessment
A literature study of human challenge experiments with inﬂuenza
virus has produced two sets of studies, with virus delivered either via
aerosol inhalation or via intranasal droplet inoculation. Aerosol
inoculation may allow the virus to reach smaller bronchiae where
receptor densities are high (Hatch, 1961) and infection may be more
likely. Alternatively, deposition of a small droplet of virus suspension
onto the nasal mucosa may serve as a model for transmission via
droplets of sedimenting sizes (Brankston et al., 2007).
To analyze these dose response data, a hierarchical model is used,
extending the hit theory model for microbial infection (Haas, 1983;
Teunis and Havelaar, 2000) to a multilevel framework (Teunis et al.,
2008b).
Dose response model
When exposed to a sample taken from a well mixed microbial
suspension the probability of exposure to one or more infectious virus
particles is
Probexp cVð Þ = 1−e−cV ð1Þ
assuming a volume V was inoculated from a suspension of Poisson
distributed particles with concentration c.
In case each particle is equally infectious, the dose response
relation for infection is (Riley and O'Grady, 1961)
Probinf cV jpmð Þ = 1−e−pmcV ð2Þ
where any infectious virus survives the host barriers to infection with
probability pm (Teunis and Havelaar, 2000). Biological variation inhost susceptibility and virus infectivity may be expressed as (random)
variation in pm. The resulting (marginal) dose response model
Probinf cV jα;βð Þ = 1−1F1 α;α + β;−cVð Þ ð3Þ
where 1F1 is a (Kummer) conﬂuent hypergeometric function and α
and β the parameters of a beta distribution describing the variation in
pm, is the beta-Poisson model for microbial infection (Haas, 1983;
Teunis and Havelaar, 2000).
A person infected with inﬂuenza virus may develop symptoms of
acute respiratory illness with probability again depending on the
inoculated dose. A conditional dose response model for illness in
infected subjects is deﬁned as
Probill j inf cV jη; rð Þ = 1− 1 + ηcVð Þ−r ð4Þ
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Fig. 2. (a) Average settling time (in s) for a particle produced at body height (1.6 m) to
reach the ﬂoor, as a function of particle diameter. (b) Horizontal distance (in m)
travelled when a particle is expelled with velocity 1 m/s and falls 0.8 m (half body
height).
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Fig. 4. Dose response for infection by wild type inﬂuenza A virus, via aerosol or
intranasal droplet inoculation. ‘Best ﬁt’ dose response relations and density graph of
predicted infection risk as a function of dose (margins span 99% interval). Also shown is
a bubble chart of observed fractions (symbol size proportional to numbers exposed).
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the duration of infection (parameters η and r describe a (gamma)
distribution for the dose dependent duration of infection). Details can
be found in Teunis et al. (1999).
As subject status is binary (infected or not, symptomatic or not) the
modelmay be analyzedwith a binomial likelihood function (Teunis and
Havelaar, 2000) that can be extended to a two-level framework (Teunis
et al., 2002, 2008b). Additional information on statistical analysis is
provided in an online appendix (supporting information).
Dose response data
Three studies administered the virus through inhalation of a
standardized aerosol of inﬂuenza A virus isolated from patients (5d
Sc ,Vc
Fig. 3. Conical region where sedimenting droplets (N10 μm) may occur after expulsion
through coughing or sneezing. The horizontal distance d (and the circular area Sc and
the corresponding volume Vc) depends on the initial velocity and the particle size.different isolates, shown in Table 1). Twelve papers reported on
inﬂuenza A virus challenge through intranasal droplet inoculation,
three of which appeared to re-report results from an earlier study,
leaving nine studies with 14 different isolates (Table 2). Note that the
oldest study (Henle et al., 1946) only documented illness responses:
numbers of infected subjects (excreting virus) were not reported.
Because illness is conditional on infection these data still provide
information about the infectivity of the virus.
In most studies the virus dose was expressed in TCID50 units. This
is the median 50% tissue culture infectious dose (TCID50). Assuming
perfect susceptibility 1 TCID50 would correspond to log2≈0.69
infectious virus particles because the dose response for a perfectly
susceptible host system is Pinf(D)=1−e−D, hence 1−e−TCID50=0.5.
This is quite close to 1 and therefore we feel safe in assuming that 1
TCID50 approximately equals 1 infectious virus particle (Blachere et
al., 2009). In one of the studies the dose was expressed as 50%
infectious dose in chick embryo culture (Henle et al., 1946). Chick
embryos are also a highly sensitive medium (Hirst, 1942) and it does
not seem very likely that the chick embryo assay is less susceptible
than the tissue culture assay by more than an order of magnitude
(Donald and Isaacs, 1954). Therefore, in the following analysis it is
assumed that 1 EID50=1 TCID50=1 virus particle.
Exposure
Droplets are generated during breathing, coughing or sneezing as
expelled air strikes surfaces covered with mucus in the upper
respiratory tract. Various accountshavebeenpublishedof thediameters
of the ﬂuid particles produced during either of these activities, with
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Fig. 5. Dose response for illness given infection by wild type inﬂuenza A virus, via
aerosol or intranasal droplet inoculation. ‘Best ﬁt’ dose response relations and density
graph of predicted conditional illness risk as a function of dose. Also shown is a bubble
chart of observed fractions (symbol size proportional to numbers infected).
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droplet inoculation. ‘Best ﬁt’ dose response relations and density graph of predicted
illness risk as a function of dose. Also shown is a bubble chart of observed fractions
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al., 2009). A review of airborne infectious particle emission (Nicas et al.,
2005) describes three different studies reporting particle size distribu-
tions. In order to not unduly complicate the following account of
airborne exposure the sizes recorded in one study (Loudon and Roberts,
1967)will be used, because that studyprovides a detailed account of the
particle size distribution, combining small non-sedimenting particles
and large size particles that sediment rapidly. The reported particle
diameters range from 1 μm to more than 1.5 mm, and the frequencies
counted in air expelled with 90 coughs are given.
There appears to be a bimodal distribution of small and large
particles (Fig. 1) and a binary mixture of lognormal distributions
provides a good ﬁt of these observed particle sizes. Small particles
have a mean size of 3.0 μm (99% range 1.27–6.25 μm). The average
diameter of large particles is 111.4 μm (99% range 8.7–616.6 μm). A
little less than half of the particles is in the small size class (48.3%).
Note that, assuming spherical particles, this means that the total
volume in the small particle class is about 2.4×10−6 of the total
volume of all expelled particles.
Sedimentation of ﬂuid particles
A very basic description of sedimentation of ﬂuid particles can be
given by considering only gravitational and frictional forces
(
mx″ tð Þ = −bx′ tð Þ
my″ tð Þ = −by′ tð Þ−mg
(
x 0ð Þ = 0; x′ 0ð Þ = a
y 0ð Þ = h; y′ 0ð Þ = 0 ð5Þ
where x and y are horizontal and vertical distances, m is the mass of
the ﬂuid particle, g is the gravitational constant and b is a frictionalcoefﬁcient. Initial height above the ﬂoor is h (m) and particles are
expelledwith initial horizontal velocity a (m/s). For spherical particles
m =
4
3
πr3ρ kgð Þ; b = 6πηr kg s−1
 
ð6Þ
where η=1.82×10−5 (kg m−1 s−1) and g=9.81 (m s−2). Eq. (5)
can be solved to yield
x tð Þ = am
b
1−e−
b
mt
 
; y tð Þ = h−mg
b
t +
m2g
b2
1−e−
b
mt
 
ð7Þ
so that the time a particle is suspended can be estimated (Fig. 2a). For
a given initial velocity the horizontal distance travelled appears to
only depend on particle diameter in a fairly narrow range, from 40 μm
to 1 mm (Fig. 2b).
A sedimenting particle is assumed to be expelled in a random
direction within a cone shaped region (Tang et al., 2009) of solid angle
α steradians (1 steradian corresponds to an apex angle of≈65.5° in a
cross-section of the cone). The surface area of the base of the cone (as
a spherical cap) is
Sc = αd
2 ð8Þ
when d is the horizontal distance travelled by the particle. See Fig. 3.
The volume of the cone is approximately
Vc =
πd3
3
1− α
2π
 
+
α2d3
4π
1− α
6π
 
ð9Þ
(Nicas and Sun, 2006; Atkinson and Wein, 2008).
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Fig. 7. Distribution of single virus unit infectivity for wild type inﬂuenza A virus, via
aerosol inoculation and via intranasal droplet inoculation. Density chart determined
from (posterior) predictive distribution of the infectivity parameters.
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If a person resides in a room with little ventilation where another
infected person produces virus suspended in aerosol, the probability
of inhaling a suspended particle (e.g. a droplet nucleus) is
Pinhal τ;Q r ;V0ð Þ = 1−e−
Q rτ
V0 ð10Þ
assuming perfect mixing, where V0 is the room volume (m3), Qr is the
respiration rate (m3 s−1) and τ is the residence time, i.e. the average
time the particle remains in suspension (as in Fig. 2a). It will be
assumed that the respiration rate is 50 l/min and the room volume is
3×4×4=48 m3. When the receiving subject remains in the room for
a deﬁned period T, say 1 h, the probability of inhalation is determined
by Min(τ,T) instead of τ.
Droplet inoculation
In the same situation as above: a closed room with a person
coughing, and another person who may be close enough to be
exposed, the probability of contact with sedimenting infectious
droplets may be considered. Above (sedimentation of ﬂuid particles)
the volume of space was calculated where an expelled droplet may be
found (Eq. (9), see Fig. 3).
Assuming that contact with such a droplet may occur in a rectangular
volumewhere the receivingperson canbe (ina roomof4×4m2avolume
of approximately 2×16=32m3) the probability of contact is propor-
tional to Vc/32. A small fraction of the exposed body surfaces is mucosa
(Nicas and Sun (2006) assume 15 cm2=15×10−4 m2) and the
probability of a droplet hitting exposed mucosa is proportional to15×10−4/Sc. The probability of contact through a sedimenting infectious
droplet then is
Pdroplet =
15 × 10−4
32
Vc
Sc
= Kd ð11Þ
with d again the horizontal distance travelled by the droplet, and
K =
15 × 10−4
16 × 9:6
π
3
1− α
2π
 
+
α2
4π
1− α
6π
  ! 1
α
ð12Þ
where the solid angle α describes the dispersion in direction of
sedimenting droplets.
Simulation of exposure
The following scenario was assumed: an infectious person
produces droplets containing virus by coughing, with size distribution
as in Fig. 1. The median horizontal velocity was assumed to be 2 m/s,
its maximum (95 percentile) 12.5 m/s, and a gamma distribution was
used to simulate its variation (parameters r=0.65, λ=5.48). Based
on a hierarchical model analysis of nasal excretion data (Baccam et al.,
2006) the concentration of virus was assumed to be lognormal with
geometric mean 108 and 95% range 105–1012 (m−3). At the time of
coughing another person enters the room and remains there for 1 h,
while there is neither little ventilation nor strong air movements.
The probabilities of exposure and infection (and acute symptoms
of respiratory illness) were estimated for a single infectious particle
(either sedimenting or non-sedimenting), and for a coughing attack
consisting of a Poisson distributed number of coughs (15 coughs
average) and negative binomially distributed numbers of particles per
cough, average 466 (Loudon and Roberts, 1967), and dispersion
parameter ρ=10 (Teunis et al., 2008b). The resulting distribution of
numbers of particles is shown in Fig. 10a.
Virus inactivation due to aerosol formation and drying was not
accounted for because it is likely that the periods required are longer
than the 1 h scenario assumed here. A reduction in infectivity of less
than 1 log unit has been reported after 6 h suspension in air room
temperature (Harper, 1961), at high humidity survival may be lower
(Hemmes et al., 1960).
Results
Dose response assessment
The dose response relations for infection, illness among infected,
and illness are shown in Figs. 4–6. These graphs show ‘best ﬁt’ dose
response relations for all individual isolates, as well as the (posterior)
density of the predicted probabilities (of infection, illness given
infection, or illness unconditionally). The latter densities can be
thought of as estimates of infection or illness risk, generalized from
the complete set of included dose response relations. The outer
margins correspond to a 99% predictive interval. See online support-
ing information for more explanation and additional results. Also
shown are the observed fractions, as far as these can be calculated.
The dose response relation for infection is completely determined
by the infectivity of a single infectious unit (pm in the model described
above). Its distribution can also be determined, as shown in Fig. 7, for
aerosol and intranasal droplet inoculation.
Aerosol inoculation of inﬂuenza A virus (Fig. 4a) results in high
infectivity, mainly because of the responses to low doses (Jao et al.,
1965; Alford et al., 1966).
Aerosol inoculation is about 20 times as efﬁcient as intranasal
droplets in causing infection, but with greater variability (Fig. 7).
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Fig. 8. Probabilities of contact with a ﬂuid particle (a), exposure to infectious virus (b), infection (c), and symptoms of acute respiratory illness (d), as a function of the diameter of the
expelled particle. Histograms for the two different transmission routes, aerosol inhalation and droplet inoculation, are shown in blue and red, respectively.
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Fig. 9. Box plots of simulated risk of exposure to infectious virus, infection, and acute
respiratory illness, when in the given scenario a single infectious particle is produced,
either non-sedimenting (aerosol) or sedimenting (droplet). Boxes indicate quartiles,
whiskers 95% ranges, and the horizontal lines indicate mean risks.
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Using the scenario outlined above a Monte Carlo simulation of the
risks of exposure (i.e. inhalation or mucosal contact with at least one
infectious virus particle) and infection can be simulated. The
conditional dose response relations for acute illness among infected
subjects may be used to also estimate illness risks.
The probability of contact with an expelled ﬂuid particle as a
function of its diameter is shown in Fig. 8a, for sedimenting and non-
sedimenting particles. Also shown are the probabilities of exposure to
virus, infection, and acute respiratory symptoms (Figs. 8b–d).
Fig. 9 shows risks associated with the presence of a single
infectious particle, either non-sedimenting (aerosol) or sedimenting
(droplet), with diameter drawn at random from the distribution
deﬁned by Loudon and Roberts (1967). The probability of exposure
due to either transmission route is approximately equal, as is the
infection risk. The probability of acute respiratory symptoms is higher
with droplets, because the dose involved is likely to be higher. Note
that the distribution of risk is highly skewed, with mean risks near the
95 percentile or even above that level.
The simulated risks associated with the production of a greater
number of infectious particles is shown in Fig. 10, for the numbers of
particles corresponding to a coughing attack.
Discussion
Previous studies on exposure issues in transmission of inﬂuenza
have considered epidemic dynamics (Atkinson andWein, 2008; Chenet al., 2009; Li et al., 2009) or not, dealing only with transmission
mechanisms (Nicas and Sun, 2006; Nicas and Jones, 2009). All of these
studies have ignored heterogeneity, both in virus infectivity (and
pathogenicity) and in susceptibility of the human hosts. Use of a
hierarchical framework has not only allowed us to use a two-
parameter model that includes a (beta) distribution characterizing
heterogeneity at the level of the single challenge study, but also to
characterize the variation among studies, representing different virus
isolates.
It should be noted that volunteers in human challenge studies
usually are young adults in good general health, selected to not
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Fig. 10. Numbers of particles expelled in a coughing attack (a) and box plots of
simulated risk of exposure to infectious virus, infection, and acute respiratory illness
(b). Boxes indicate quartiles, whiskers 95% ranges, and the horizontal lines indicate
mean risks.
221P.F.M. Teunis et al. / Epidemics 2 (2010) 215–222develop severe illness. Although often the immune status of the
volunteers is not known, especially in the older studies, the high
observed infection and illness rates suggest low levels of immunity to
infection or illness. In immune subjects the probability of illness (and
possibly infection) is lower than in those with no immunity, given
equal exposure. Therefore, when repeated exposure to similar virus
strains is likely, the health risks may be lower than estimated here.
The dose response relation for illness among infected subjects
implies that low dose exposure may lead to infection, due to the high
infectivity of the virus, but of those infected only a small proportion
may become ill. Exposure to high doses of virus results in most of the
infected subjects also becoming ill. A shedding event releasing high
numbers of viruses in the environmentmay therefore lead to clusters of
cases that can be detected in disease surveillance. Where low numbers
of viruses are present transmission may be mostly asymptomatic, and
the odd person developing symptoms cannot easily be linked to other
cases infected by the same source. When exposure to airborne virus is
reduced, for instance by population-wide use of facemasks, the relative
decrease in numbers of illnesses is expected to be greater than the
relative decrease in transmission, by numbers infected.
The quantitative characterization of inﬂuenza virus infectivity
(and pathogenicity) provides a stronger basis for prospective studies
of the effects of interventions, in particular those interventions that
reduce exposure, for instance, the effect of face mask use on spread of
pandemic inﬂuenza (Brienen et al., 2010).
In calculating the virus content of differently sized particles the
virus concentration was assumed constant so that, given the virus
concentration, the number of viruses in a particle of any size depends
only on its volume. Sequestration of virus into ﬂuid particles may
however not be independent of particle size, and if this were the case
the relative contributions of variously sized particles to exposure,
infections and symptoms as shown in Fig. 7 may change.
It is worth noting here that virus in suspension may often be
aggregated, causing thevirus to bepresent in clumpsof variable numbersof single viruses or virions, instead of a fully dispersed suspension of
virions (Wei et al., 2007). If the inoculum should contain aggregates the
effect on the dose response relation would be an increase in apparent
heterogeneity (compared to a monodisperse suspension of the same
virus): any suspendedparticle thenmayconsist of 1 ormorevirions, each
of variable infectivity (Teunis et al., 2008a).
In freshly shedded inﬂuenza virus most particles may be
infectious: particle counts and TCID50 do not differ greatly (Wei et
al., 2007). Even the EID50, the 50% infectious dose in chick embryo
culture has been estimated to correspond to less than 10 particles, also
supporting the assumption that TCID50 and EID50 are approximately
equal. However, when the virus has been exposed to environmental
conditions the fraction infectious particles may decrease rapidly
(Horsfall, 1954, 1955; Choppin and Tamm, 1960). Such loss of
infectivity may not be important in the scenario considered here,
but must be taken into account when considering exposure to virus in
natural conditions.
The estimated probabilities of exposure and infection are within
the same order of magnitude, indicating that one cannot readily
discard either route as unimportant for transmission. The advantage
of sedimenting droplets carrying a higher virus load is compensated
by their smaller chance of contact combinedwith the lower infectivity
of upper respiratory tract inoculation. Similarly, the more efﬁcient
inoculation of small aerosol particles is compensated by their smaller
virus content. For example, outdoor aerosol transmission is not likely
due to dilution and dispersion by ambient wind speeds and
turbulence, whereas in closed environments, particularly with low
ventilation, aerosol transmission is more likely.
Despite equal infection risks, the corresponding risks of acute
respiratory illness are somewhat higher for droplets, due to the higher
dose that is involved with larger particles.
Inﬂuenza virusmay also be transmitted through hand contact with
contaminated surfaces. Surface-to-hand-to-mucosa contacts were not
considered in this study because the aim was to compare aerosol and
droplet transmission in the absence of human behavioural factors, as
these are poorly understood and the proximity of infectious and
susceptible subjects cannot be easily quantiﬁed.
To improve the estimates of transmission of respiratory virus,
further studies of exposure are needed, to determine how efﬁciently
airborne virus may be transferred in the presence of ventilation, the
relation between human contact behaviour and droplet infection, and
most importantly, the role of contaminated surfaces in transmission of
inﬂuenza.
Supplementarymaterials related to this article can be found online
at doi:10.1016/j.epidem.2010.10.001.
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